|
T2584 |
Octreotide
|
SMS 201-995 |
Somatostatin
|
|
Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin. |
|
T11798 |
L-692429
|
MK-0751 |
GHSR
,
GPCR19
|
|
|
|
T39262L |
BIM-23190 aceate
|
|
Somatostatin
|
|
BIM-23190 aceate, a somatostatin analog, a selective agonist of SSTR2 and SSTR5. BIM-23190 can be used in cancer and acromegaly studies. |
|
T9692 |
Paltusotine
|
|
Somatostatin
|
|
Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients |
|
T20534 |
Lanreotide
|
BIM 23014,Somatulin,Lanreotide Autogel,Somatuline,Ipstyl |
|
|
Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours. |
|
T39262 |
BIM-23190
|
|
|
|
BIM-23190 is a somatostatin analog that acts as a selective agonist for SSTR2 and SSTR5 receptors. It displays potency with K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 finds utility in ... |
|
T37109 |
BIM-23190 hydrochloride
|
|
|
|
BIM-23190 hydrochloride, a selective agonist for somatostatin receptors SSTR2 and SSTR5 with Ki values of 0.34 nM and 11.1 nM respectively, is a somatostatin analog utilized in research on cancer and acromegaly[1][3]. |
|
T75157L |
Cimdelirsen sodium
|
|
|
|
Cimdelirsen is a novel, ligand-conjugated, hepatic-targeted investigative antisense oligonucleotide designed to reduce growth hormone receptor (GHr) synthesis, thereby inhibiting deleterious effects of growth hormone (GH... |
|
T75157 |
Cimdelirsen
|
|
|
|
Cimdelirsen, a novel ligand-conjugated, hepatic-targeted antisense oligonucleotide under investigation, aims to diminish growth hormone receptor (GHr) synthesis. This inhibits the harmful effects of growth hormone (GH) h... |
